AVITA Medical, Inc.
DE ˙ DB ˙ US05380C1027
6,35 € ↓ -0,05 (-0,78%)
2025-05-13
DEL PRIS
SecurityDE:51KA / AVITA Medical, Inc.
InstitutionJpmorgan Chase & Co
Latest Disclosed Ownership5,915 shares
Latest Disclosed Value $ 21,471
Jpmorgan Chase & Co reports 16.32% increase in ownership of 51KA / AVITA Medical, Inc.

On May 13, 2026 - Jpmorgan Chase & Co filed a 13F-HR/A form disclosing ownership of 5,915 shares of AVITA Medical, Inc. (DE:51KA) valued at $21,471 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 5,085 shares of AVITA Medical, Inc.. This represents a change in shares of 16.32% during the quarter. The current value of the position is $37,560 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F/A-1 AVITA MEDICAL COMMON 05380C102 5,915 830 16.32 21 23.53 0.0000
2026-05-13 2026-03-31 13F AVITA MEDICAL COMMON 05380C102 0 -100.00 0
2026-02-11 2025-12-31 13F AVITA MEDICAL COMMON 05380C102 5,085 -182 -3.46 18 -34.62 0.0000
2025-11-26 2025-09-30 13F/A-1 AVITA MEDICAL COMMON 05380C102 5,267 -7,789 -59.66 27 -62.32 0.0000
2025-11-07 2025-09-30 13F AVITA MEDICAL COMMON 05380C102 5,267 -7,789 27 0.0000
2025-08-12 2025-06-30 13F AVITA MEDICAL COMMON 05380C102 13,056 463 3.68 69 -32.35 0.0000
2025-05-12 2025-03-31 13F AVITA MEDICAL COMMON 05380C102 12,593 -40,113 -76.11 103 -84.87 0.0000
2025-02-12 2024-12-31 13F AVITA MEDICAL COMMON 05380C102 52,706 20,362 62.95 675 94.80 0.0001
2024-12-26 2024-09-30 13F/A-1 AVITA MEDICAL COMMON 05380C102 32,344 8,985 38.46 347 87.03 0.0000
2024-11-08 2024-09-30 13F AVITA MEDICAL COMMON 05380C102 32,344 8,985 347 0.0000
2024-12-26 2024-06-30 13F/A-1 AVITA MEDICAL COMMON 05380C102 23,359 13,075 127.14 185 12.80 0.0000
2024-08-12 2024-06-30 13F AVITA MEDICAL COMMON 05380C102 23,359 13,075 185 0.0000
2024-12-26 2024-03-31 13F/A-1 AVITA MEDICAL COMMON 05380C102 10,284 -6,344 -38.15 165 -28.07 0.0000
2024-05-10 2024-03-31 13F AVITA MEDICAL COMMON 05380C102 10,284 -6,344 165 0.0000
2024-12-26 2023-12-31 13F/A-1 AVITA MEDICAL COMMON 05380C102 16,628 -433 -2.54 228 -8.43 0.0000
2024-02-12 2023-12-31 13F AVITA MEDICAL COMMON 05380C102 16,628 -433 228 0.0000
2023-11-14 2023-09-30 13F AVITA MEDICAL COMMON 05380C102 17,061 -2,431 -12.47 249 -24.77 0.0000
2023-08-11 2023-06-30 13F AVITA MEDICAL COMMON 05380C102 19,492 12,846 193.29 332 255.91 0.0000
2023-05-18 2023-03-31 13F/A-1 AVITA MEDICAL COMMON 05380C102 6,646 6,646 93 0.0000
2023-05-11 2023-03-31 13F AVITA MEDICAL COMMON 05380C102 6,646 6,646 93 0.0000
2022-08-11 2022-06-30 13F AVITA MEDICAL COMMON 05380C102 0 -17,501 -100.00 0 -100.00
2022-05-11 2022-03-31 13F AVITA MEDICAL COMMON 05380C102 17,501 -50,529 -74.27 149 -81.72 0.0000
2022-02-11 2021-12-31 13F/A-1 AVITA MEDICAL COMMON 05380C102 68,030 17,902 35.71 815 -8.32 0.0001
2022-02-10 2021-12-31 13F AVITA MEDICAL COMMON 05380C102 68,030 17,902 815 0.0001
2021-11-12 2021-09-30 13F AVITA MEDICAL COMMON 05380C102 50,128 40,962 446.89 889 372.87 0.0001
2021-08-12 2021-06-30 13F AVITA MEDICAL COMMON 05380C102 9,166 9,166 188 0.0000
2020-11-12 2020-09-30 13F/A-1 AVITA THERAPEUTICS COMMON 05380C102 0 -30,471 -100.00 0 -100.00
2020-08-11 2020-06-30 13F AVITA THERAPEUTICS COMMON 05380C102 30,471 25,853 559.83 931 3,110.34 0.0002
2020-05-12 2020-03-31 13F AVITA MEDICAL ADR 053792107 4,618 4,618 29 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.